ADA Scientific Sessions 2025 Abstract
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
ReviewBiomarkers
The paper
Burlingame
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, late-breaking 2106-LB